Institute of Biochemistry logo Institute of Biochemistry
Center of Excellence in Molecular Life Sciences
Molecular and Cellular Biology Analytical and Preparative Biochemistry Proteomics Interactomics Bioinformatics and Biocomputing

Protein Tyrosine Phosphatases: Structure, regulation and biological function

Protein Tyrosine Phosphatases: Structure, regulation and biological function 2007 - 2011
Acronym: PTPNET
Budget: Total € 2.965.480/ Cost for IBAR € 145.231
Project director: Stefan Szedlacsek
Grant agreement ID: 35830
External website: full link

Project Funded under: Human resources and Mobility in the specific programme for research, technological development and demonstration "Structuring the European Research Area" under the Sixth Framework Programme 2002-2006. PTPNET was a Training Network for young scientists in the field of protein tyrosine phosphatase (PTP) research.

PTPs are protein with enzymatic properties and a range of cellular and tissue functions. PTPs participate in the control of embryo development and normal physiology in humans, while PTPs are also causative for  a number of diseases. However, general knoledge of PTP function lags far behind that of many other proteins, and thus PTPNET was established to adress many pressing questions in the field.

These included the Consortium's desire to understand protein structure and regulation, how PTPs send inside cells and tissues, and how PTPs are involved in embryonic development and diseases such as cancer, multiple sclerosis and osteoporosis.



 
Stefan Szedlacsek, Dr.
Stefan Szedlacsek, Dr.

Head of Department

Prof. Dr. Stefan Szedlacsek is the Head of the Enzymology Department at the Institute of Biochemistry of the Romanian Academy. He holds a PhD degree in Biotechnology from Polytechnical University of Bucharest as well as a MSc in Organic Synthesis (Polytechnical University, Bucharest) and MSc in Mathematics (University of Bucharest). As a visiting scientist, he performed research in the field of cholesterol metabolism at the University of Illinois at Urbana-Champaign (USA), where he succeeded to evidence a new pathway in the metabolism of oxysterols.  He is an “Alexander von Humboldt” fellow and worked in Germany, in the Institute of Biochem More...

The overarching, scientific objective of the Network Programme is to provide fundamental advances in our understanding of the molecular, cellular and tissue functions of protein tyrosine phosphatase (PTP) enzymes, under normal cellular conditions and in diseased states.  A diverse range of PTPs will be studied, including receptor-like and cytoplasmic enzymes, and multidisciplinary approaches will be brought to bear. Our ultimate goal is to bring the field to the point where there is a real possibility of progressing into translational research on a broad front, applying knowledge to PTP-based therapeutics.

There are four main scientific objectives of the Consortium:

Objective 1 - Understanding the Structural Basis of PTP signalling

Objective 2 - Understanding the Mechanisms and Dynamics of PTP Regulation

Objective 3 - Understanding the Role of PTPs in Development and Disease

Objective 4 - Development of Novel Bioinformatics Resources for the PTP Research Community

PTPNET Consortium

PTPNET logo
PTPNET Romanian Team
Partner 4   Institute of Biochemistry of the Romanian Academy
Department of Enzymology   2007-2011
Professor Ștefan Szedlacsek
GROUP LEADER
Professor Ștefan Szedlacsek
Institute of Biochemistry of the Romanian Academy
Department of Enzymology, Bucharest, Romania
Splaiul Independenței nr. 296, Sector 6
Mihaela Bălașu
POSTDOCTORAL FELLOW
Mihaela Bălașu
Sujay Turuvekere Mallikarjuna
ESR TRAINEE
Sujay Turuvekere Mallikarjuna
Rodica-Aura Badea
PHD STUDENT
Rodica-Aura Badea
Georgiana Petrăreanu
PHD STUDENT
Georgiana Petrăreanu
Mihaela Mențel
PHD STUDENT
Mihaela Mențel
Adina Mariana Monea
ASSISTANT
Adina Mariana Monea

PTPNET Consortium Final Results

PTPNET logoFinal Results of the Romanian TeamPTPNET, Partner 4, Institute of Biochemistry of the Romanian Academy
I. Experimental Results
  1. Both the full-length hEya3 gene and the C-terminal domain of hEya3 (hEya3ED) were cloned using a cDNA library.
  2. Experiments using phosphorylated peptides did not demonstrate that hEya3 could autodephosphorylate at the proposed sites.
  3. Enzymatic activity measurements of full-length hEya3 and hEya3ED using pNPP indicated that the N-terminal domain of hEya3 did not influence its phosphatase activity under the conditions tested.
  4. A substantial difference was observed when enzymatic activity was measured using DiFMUP: hEya3ED exhibited no detectable activity, possibly because it lacked the native conformation.
  5. The team reported, for the first time, enzymatic activity in a full-length Eyes absent protein. Preliminary assays suggested that high concentrations of pNPP inhibited hEya1 activity.
  6. In investigating PLCγ2 as a potential substrate of RPTPμ, pull-down experiments using a series of RPTPμ mutant proteins confirmed an interaction between the two proteins and demonstrated that they could be efficiently co-precipitated from cells.
  7. The catalytic domain of RPTPμ was shown to dephosphorylate PLCγ2 at both pY753 and pY759. These residues are involved in PLCγ2 activation, suggesting possible physiological significance. The results strongly suggested that PLCγ2 is a bona fide substrate of RPTPμ.
II. Organization of Workshops and Courses
  • The Institute of Biochemistry (IBI) organized the FEBS Advanced Course “Recombinant DNA Technology and Protein Expression” in Bucharest, 7 to 14 September 2008.
  • An early-stage researcher (ESR) from the Institute of Biochemistry (Partner 4) and a team member from Jena University Hospital attended the practical and theoretical course.
III. Training and Secondments: Sujay Turuvekere Mallikarjuna
  • Participated in the PTPNET meeting in Manchester, United Kingdom, 13 to 18 June 2008, and presented research results.
  • Attended the “Bioinformatics and Crystallography Workshop” in Manchester, 13 to 18 June 2008, and the FEBS Advanced Course “Recombinant DNA Technology and Protein Expression” in Bucharest, 7 to 14 September 2008.
  • Completed a secondment at the University of Oxford (Partner 10), 1 to 31 July 2008.
PTPNET logo
PTPNET Dissemination
Publications and scientific presentations
Published Papers

1. “Protein tyrosine phosphatases: structure-function relationships”Authors: Tabernero, L.; Aricescu, A. R.; Jones, E. Y.; Szedlacsek, S. E.FEBS Journal, 2008, 275(5), 867-882. DOI: 10.1111/j.1742-4658.2008.06251.x

2. “Interface analysis of the complex between ERK2 and PTP-SL”Authors: Balasu, M. C.; Spiridon, L. N.; Miron, S.; Craescu, C. T.; Scheidig, A. J.; Petrescu, A. J.; Szedlacsek, S. E.PLoS ONE, 2009, 4(5). DOI: 10.1371/journal.pone.0005432

3. “Large scale mammalian expression and purification of protein tyrosine phosphatase PTPBR7”Authors: Mallikarjuna, Sujay Turuvekere; Szedlacsek, Stefan E.Romanian Journal of Biochemistry, 2012, 49(1), 13-20.

4. “Identification of protein tyrosine phosphatase substrates”Authors: Mallikarjuna, S. T.; Szedlacsek, S. E.Romanian Journal of Biochemistry, 2012, 49(1).

5. “Protein tyrosine phosphatase structure-function relationships in regulation and pathogenesis” Authors: Böhmer, F.; Szedlacsek, S.; Tabernero, L.; Östman, A.; den Hertog, J. FEBS Journal, 2013, 280(2), 413-431. DOI: 10.1111/j.1742-4658.2012.08655.x

Book Chapter

1. “Expression, Purification, and Kinetic Analysis of PTP Domains”Authors: Mentel, M.; Badea, R. A.; Necula-Petrareanu, G.; Mallikarjuna, S. T.; Ionescu, A. E.; Szedlacsek, S. E.Methods in Molecular Biology, 2016, vol. 1447, pp. 39-66. DOI: 10.1007/978-1-4939-3746-2_3

Poster Presentations

1. “Enzymatic Characterization of a New Isoform of Human Eyes Absent Homolog 3” Mihaela Pascaru; Stefan E. Szedlacsek 29-31 May 2008. Bucharest, Romania. The Annual International Conference of RSBMB.

2. “Structure-function analysis of Eyes absent proteins - aspartate dependent protein tyrosine phosphatases” Mihaela Pascaru; Stefan E. Szedlacsek 23-31 August 2008. Osaka, Japan. Congress of the International Union of Crystallography.

3. “New evidence for PLC γ2 as a potential substrate of RPTP μ” Rodica Badea; Mihaela Mentel Pascaru; Stefan Szedlacsek 14-18 July 2009. Egmond aan Zee, Netherlands. The Europhosphatase Conference.

4. “Expression and crystallization trials of FERM and KIND domain of PTPL1/BL” Sujay Mallikarjuna; Mihaela Mentel; Stefan Szedlacsek 14-18 July 2009. Egmond aan Zee, Netherlands. The Europhosphatase Conference.

Oral Presentations

1. “Purification and crystallization of proteins during the PTPNET Marie Curie training network: Bioinformatics and Crystallography” Stefan Szedlacsek 13-18 June 2008. Manchester, United Kingdom. Seminar / Workshop.

2. “Prokaryotic expression, purification and crystallization trials of FERM domain of PTP-BL/PTP-L1” Sujay Turuvekere Mallikarjuna; Stefan Szedlacsek 8-14 September 2008. Bucharest, Romania. FEBS Advanced Theoretical and Practical Course: Recombinant DNA Technology & Protein Expression.

3. “Prokaryotic expression, purification and crystallization trials of KIND and FERM domain of PTP-BL/PTP-L1” Sujay Turuvekere Mallikarjuna; Stefan Szedlacsek 10 October 2008. Bucharest, Romania. Institute of Biochemistry.

4. “Back in time to the origins of protein tyrosine phosphatases” Stefan Szedlacsek 21-24 September 2010. Bucharest, Romania. The Diaspora Conference, Trends in Medical Genomics and Proteomics.